Microsomal warfarin binding and vitamin K 2,3-epoxide reductase

Area of Science:

• Pharmacology
• Biochemistry
• Molecular Biology

Background:

• 4-hydroxycoumarin anticoagulants, like warfarin, are crucial therapeutic agents.
• Understanding their molecular targets is essential for optimizing drug efficacy and managing resistance.
• Rat liver microsomes are key sites for drug metabolism and target interaction.

Purpose of the Study:

• To investigate the relationship between 4-hydroxycoumarin binding in rat liver microsomes and the enzyme vitamin K epoxide reductase.
• To characterize warfarin binding properties in different warfarin-resistant rat genotypes.
• To explore the impact of S-warfarin administration on microsomal binding and enzyme activity.

Main Methods:

• Assaying specific [14C]warfarin binding to rat liver microsomes.
• Utilizing dithiothreitol to assess the role of vitamin K epoxide reductase activity.
• Comparing warfarin binding in microsomes from warfarin-sensitive and resistant rat genotypes.
• Administering S-warfarin to rats and analyzing subsequent microsomal binding and enzyme activity.

Main Results:

• Warfarin-sensitive rat microsomes exhibited significant specific binding sites for [14C]warfarin.
• Dithiothreitol pretreatment reduced warfarin binding, suggesting a link to vitamin K epoxide reductase activity.
• Microsomes from the Welsh warfarin-resistant genotype showed reduced warfarin binding.
• S-warfarin administration linearly decreased warfarin binding and inhibited vitamin K epoxide reductase activity.

Conclusions:

• Microsomal 4-hydroxycoumarin binding is directly related to the target enzyme, vitamin K epoxide reductase.
• Warfarin resistance mechanisms can involve alterations in target enzyme binding affinity.
• These findings provide insights into the molecular basis of warfarin action and resistance.